Background: The glutathione (GSH) pathway has been implicated in cellu
lar resistance to cytotoxic agents. There is strong evidence that oxaz
aphosphorine analogues may alter cellular GSH concentrations. Therefor
e, we analyzed the effects of the prodrugs 4-hydroperoxy-ifosfamide [4
-OOH-IF] and -cyclophosphamide [4-00H-Cy] on the cellular GSH pathway
and the antitumor efficacy of cisplatin in human cancer cells using is
obologram analysis. Methods: Cytotoxicities to COOH-IF and 4-OOH-Cy in
human ovarian A2780 and cisplatin-resistant A2780CP2 cells, breast ca
ncer cell lines MCF-7 and MB231 were determined using the sulphorhodam
ine B (SRB) assay. Determinations of cellular GSH concentrations and G
SH-peroxidase activities were performed 2 h and 24 h after drug exposu
re to either 4-OOH-IF or 4-OOH-Cy. Drug interactions of cisplatin eith
er with 4-OOH-IF or 4-OOH-Cy were assessed using standard isobologram
methodology (50% isodose), and were classified as synergistic, additiv
e or antagonistic. Results: While A2780CP2 cells were 5.4-fold resista
nt to cisplatin, only 2.5-fold and 3.9-fold cross-resistance to 4-OOH-
Cy and 4-OOH-IF was observed, respectively. Maximum depletion of cellu
lar GSH was achieved in breast cancer cell lines and peaked two hours
after administration of 4-OOH-IF However, complete restoration of GSH
contents were observed 24 h after drug exposure and no significant alt
erations of GPx activities were found. Using isobologram analysis conc
urrent 2-hour exposure to 4-OOH-IF and cisplatin led to additive drug
interactions. Using the same conditions, exposure to 4-OOH-Cy and cisp
latin resulted in additive to antagonistic interactions. Conclusions:
Exposure to 4-hydroperoxyifosfamide leads to significant depletion of
cellular GSH concentrations and may, therefore, schedule dependently p
otentiate the antitumor efficacy of other anticancer agents (e. g., ci
splatin, anthracyclines).